Gain Therapeutics Inc (NASDAQ:GANX), a company specializing in the development of novel therapeutics to treat central nervous system and lysosomal storage diseases, has seen a notable insider transaction.
Related Keywords
Jeffrey Riley , Gain Therapeutics Inc , Gurufocus Value , Significantly Overvalued , Director Jeffrey Riley ,
comparemela.com © 2020. All Rights Reserved.